Armistice Capital, LLC Immunovant, Inc. Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
A detailed history of Armistice Capital, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 3,396,909 shares of IMVT stock, worth $93.4 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
3,396,909
Previous 2,164,000
56.97%
Holding current value
$93.4 Million
Previous $69.9 Million
28.26%
% of portfolio
1.17%
Previous 0.95%
Shares
4 transactions
Others Institutions Holding IMVT
# of Institutions
215Shares Held
65.3MCall Options Held
697KPut Options Held
629K-
Vanguard Group Inc Valley Forge, PA6.51MShares$179 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.92MShares$135 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.88MShares$79.3 Million2.5% of portfolio
-
State Street Corp Boston, MA2.72MShares$74.8 Million0.0% of portfolio
-
Viking Global Investors LP2.32MShares$63.8 Million0.24% of portfolio
About Immunovant, Inc.
- Ticker IMVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 129,077,000
- Market Cap $3.55B
- Description
- Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...